Prevent Cancer Foundation welcomes 2023 corporate members dedicated to cancer prevention and early detection

Sep 7, 2023

ふまたは即時リリース

キラ・マイスター
703-836-1746
kyra.meister@preventcancer.org

Alexandria, Va. – The Prevent Cancer Foundation today announced the first class of members in the newly launched Corporate Membership Program. A one-of-a-kind partnership, the Foundation’s Corporate Membership Program is aimed at accelerating mutual goals and reaffirming a commitment from corporate partners to advancing cancer prevention and early detection.

Program members will have access to Foundation resources and exclusive events, creating opportunities to collaborate and exchange ideas throughout the year. Member support will fund the Foundation’s essential work in four key areas: research, education, outreach and advocacy. Members will also play a critical role in embracing bold strategies and advancing the Foundation’s mission of empowering people to stay ahead of cancer through prevention and early detection.

“We are thrilled to officially launch the Corporate Membership Program, solidifying the Prevent Cancer Foundation’s valued partnerships with experts across the industry,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “Our members’ commitment to cancer prevention and early detection is essential to our work and enables us to guide people of screening age toward better outcomes for their health.”

The 2023 class of corporate members, as of the date of this publication, include:

Corporate Champions Circle

Exact Sciences
Hologic
Illumina

Corporate Innovators Circle

Daiichi Sankyo
Eisai
Guardant Health
Sanofi

The Corporate Membership Program is open to companies who support the Foundation’s vision of a world where cancer is preventable, detectable and beatable for all. Those interested in learning more about the program or how to join our corporate community can contact Jennifer Niyangoda, Vice President of Development and Marketing, at jennifer.niyangoda@preventcancer.org.

###

がん予防財団について^®

がん予防財団^® は唯一の米国-ベース非営利団体専らひたむきなに癌予防と早期検出. 研究、教育を通じて、アウトリーチおよびアドボカシー, 私たちは、数え切れないほど多くの人々ががんの診断を回避したり、早期にがんを発見して治療を成功させるのを支援してきました。私たちの原動力はがんが予防できる世界のビジョン検出可能そして打ち負かすことができるすべてのために.

財団は、2035年までに癌による死亡者数を40%減らすという課題に取り組むために立ち上がっています。これを達成するために、私たちはがんを早期に発見し、進歩させるための革新的な技術に$20百万を投資することを約束マルチがん検診、がん検診とワクチン接種へのアクセスを拡大するために$1000万医学的に十分なサービスを受けていないコミュニティを支援し、検査とワクチン接種の選択肢について一般の人々を啓蒙するために$1000万ドルを支出します。

詳細については、がん予防.